INS and type 1 diabetes mellitus: Establishing connectivity between continuous glucose monitoring (CGM) devices and insulin pumps (continuous subcutaneous insulin infusion [CSII]), leading to the development of closed‐loop ‘artificial pancreas’ systems, has transformed the management of, and living with, T1D.